Cellular and bacterial macromolecules

Cellular and bacterial macromolecules, including DNA, proteins, and lipids, serve as the collective target for agents that exert their effects through non-specific oxidative damage. This pharmacological approach involves the generation of reactive oxygen species (ROS) or free radical intermediates that chemically modify and degrade these essential components, leading to rapid loss of cellular integrity (PubMed, PMID: 24591303). For instance, metronidazole is reduced within anaerobic bacteria to form nitroso-free radicals that cause DNA strand breakage (StatPearls, NBK539728). Similarly, antiseptics like hydrogen peroxide produce hydroxyl radicals that attack a wide array of bacterial structures, while the chemotherapy agent bleomycin forms a complex with iron to generate radicals that specifically cleave DNA (PubChem, CID: 5360373). Because these targets are ubiquitous, the therapeutic utility of such drugs often depends on selective uptake or activation within the pathogen or tumor environment. The resulting widespread damage to structural and functional macromolecules effectively bypasses specific resistance mechanisms but requires careful management to avoid collateral damage to healthy host tissues (NIH, 2024).

Other names

Biological macromoleculesCellular proteins, lipids, and DNABacterial DNA and proteinsCellular targets of oxidative stress

Induction of non-specific oxidative damage via the generation of reactive oxygen species (ROS) or free radical intermediates that disrupt the structure and function of DNA, proteins, and lipids.